Final Solutions V-1,2,3,4 PDF
Document Details
Uploaded by CredibleBongos
Tags
Related
- NEET 2020 Biology Paper PDF
- Devolutiva P2 Morfo II 2022.2 PDF
- Nursing Exam Solutions 2022 - First Semester PDF
- Allen Career Institute Pre-Medical Chemistry Past Paper PDF
- Complicaciones Agudas de Diabetes Mellitus (2023) PDF
- AITS Test 02 Answer Key & Solutions (Physics, Chemistry, Botany, Zoology, 2023-24) PDF
Summary
This document contains solutions to a medical exam paper. It includes multiple choice questions. The solutions cover various topics in medical science.
Full Transcript
Variant 1 Choose one correct answer 1. VOICE JUMMER WILL NOT BE REDUCED ON THE AFFECTED SIDE WHEN 1) obstructive atelectasis 2) fibrothorax , moorings 3) hydrothorax 4) compression atelectasis 2. THE...
Variant 1 Choose one correct answer 1. VOICE JUMMER WILL NOT BE REDUCED ON THE AFFECTED SIDE WHEN 1) obstructive atelectasis 2) fibrothorax , moorings 3) hydrothorax 4) compression atelectasis 2. THE CAPACITY OF THE POLYCLINIC IS ASSESSED 1) number of medical visits per shift 2) the number of existing medical and preventive units 3) average number of visits per inhabitant per year 4) the number of occupied medical positions 3. AFTER COMPLETE IMMUNIZATION AGAINST HEPATITIS B, THE PRESENCE OF 1) HBs antigen and lack of anti- HBe 2) anti - HBs and no anti -HBcor 3) anti -HBcor and no anti- HBs 4) anti - HBs and presence of anti -HBcor 4. CLINICAL LABORATORY 1) belongs to the medical department of the polyclinic 2) belongs to the diagnostic department of the polyclinic 3) belongs to the department of prevention of the polyclinic 4) is an independent division 5. NOSOCOMIAL IS USED TO CALL PNEUMONIA ARISING 1) in a patient treated at home for another disease 2) in a previously untreated person 3) in a pregnant woman after 20 weeks of pregnancy 4) later than 48 hours after a person's hospitalization 6. EROSION IN THE ANTRAL STOMACH IS CHARACTERISTIC FOR 1) Helicobacter pylori infection 2) granulomatous gastritis 3) acute gastritis 4) autoimmune gastritis 7. A DISABILITY LEAF IS ISSUED FOR THE CARE OF A SICK CHILD AGED FROM 7 TO 15 YEARS OF OUTPATIENT TREATMENT FOR EACH CASE OF DISEASE FOR A TIME OF UP TO (DAY) 1) ten 2) fifteen 3) 7 4) thirty 8. DIFFERENTIING FEATURES OF SYSTEMIC SCLERODERMA FROM SYSTEMIC LUPUUS ERYTHEIS IS 1) detection of rheumatoid factor 2) the presence of antibodies to the Scl-70 antigen in the blood 3) the presence of single LE cells in the blood 4) lung injury 9. FOR THE DIAGNOSIS OF PHEOCROMOCYTOMA, IT IS IMPORTANT TO DEFINE 1) plasma cortisol content 2) daily excretion of aldosterone in the urine 3) plasma renin activity 4) metanephrines in blood or urine 10. RISK FACTORS FOR FIXED AIRFLOW LIMITATION IN BRONCHIAL ASTHMA ARE 1) frequent viral infections 2) rhinosinusitis 3) disease duration 4) insufficiency of therapy with inhaled glucocorticoids 11. THE EARLY IN AMYLOIDOSIS IS 1) cylindruria 2) proteinuria 3) hematuria 4) leucocyturia 12. DIC TREATMENT REGIMENS PRESENT 1) anticoagulants, antifibrinolytics 2) anticoagulants and fibrinolysis activators 1 3) plasmapheresis and fresh frozen plasma 4) antiplatelet agents and fibrinolysis activators 13. FOR THE TREATMENT OF STRONG CHRONIC CANCER PAIN, WHO RECOMMENDS 1) tramadol , codeine 2) paracetamol, mydocalm 3) morphine 4) NSAIDs, paracetamol 14. ACCORDING TO WHO CRITERIA FOR THE AGE GROUP OF 40-59 YEARS, THE THRESHOLD HEART RATE IS (BEATS PER MINUTE) 1) 180 2) 160 3) 120 4) 140 15. THE DEVELOPMENT OF PNEUMONIA IN PERSONS OF THE ELDERLY AND OLD AGE PREDISPOSE 1) stress 2) bed rest 3) overwork 4) ? overheating 16. WHEN B12 DRUGS ARE PRESCRIBED IN PATIENTS WITH B12-DEFICIENCY ANEMIA, THERAPY EFFECTIVENESS EVALUATION WILL BE INCREASED ______ LEVEL BY THE END OF __ THERAPY WEEK 1) leukocytes; one 2) reticulocytes; one 3) hemoglobin; one 4) platelets; 2 17. OVERPRODUCTION IS BASED ON THE ZOLLINGER-ALLISON SYNDROME 1) glucocorticoids 2) of hydrochloric acid 3) gastrin 4) pepsin 18. FURTHER TACTICS OF TREATMENT OF INFECTIOUS ENDOCARDITIS AFTER NORMALIZATION OF THE BODY TEMPERATURE, BUT WITH AN GROWTH OF THE PHENOMENA OF SERIOUS HEART FAILURE IS 1) plasmapheresis procedure 2) increasing the dose of diuretics and adding beta- blockers 3) antibiotic change 4) referral for surgical treatment 19. THE COMBINATION OF PROTEINURIA, ERYTHROCYTURIA, HYPOPROTEINEMIA, EDEMAS IS CHARACTERISTIC FOR 1) urolithiasis 2) acute glomerulonephritis 3) pyelonephritis 4) renal amyloidosis 20. MEANS WITH INCRETIN ACTIVITY ARE SUGAR-REDUCING DRUGS OF THE GROUP 1) gliptins 2) glinides 3) glitazones 4) biguanides 21. THE DRUG IN THE THREE-COMPONENT H. PYLORI ERADICATION SCHEME IS 1) clarithromycin 2) cefazolin 3) vancomycin 4) kanamycin 22. ANGULAR STOMATITIS AND SKIN CRACKS DURING INSPECTION ARE DETECTED WHEN 1) sideropenic syndrome 2) dehydration 3) hyperestrogenemia 4) hemorrhagic syndrome 23. THE ANTI-TUMOR DRUG HAS A CARDIOTOXIC EFFECT UP TO THE DEVELOPMENT OF SECONDARY DILATED CARDIOMYOPATHY 1) sarcolysin 2) bleomycin 3) dactinomycin 4) doxorubicin 24. SELECTION OF THE DOSE OF UNFRACTIONATED HEPARIN IS CARRIED OUT USING THE DETERMINATION 1) international normalized ratio 2 2) soluble fibrin- monomer complexes with fibrinogen 3) activated fibrin protein recalcification time 4) activated partial thromboplastin time 25. IN A PATIENT WITH FREQUENT COPD EXAMINATIONS AND POST-BRONCHODILATION FEV1